Northern Trust is helping to fund a $4.75 million comprehensive home-based asthma program, known as the New York Healthy Homes Collaborative, to improve quality of life for 850 New York City children and adults on Medicaid.
As a middle school math teacher in Woodbridge, Virginia, Dr. Arik King saw firsthand how boys of color trailed their peers in test scores, attendance, and graduation rates—part of an alarming and persistent national trend.
Illumina Inc. (NASDAQ: ILMN) today announced a partnership with Boehringer Ingelheim to develop companion diagnostics (CDx) for several programs in Boehringer Ingelheim's oncology pipeline. The partnership aims to accelerate the development of therapy selection and precision medicines for patients with advanced cancer.
Illumina, Inc. (NASDAQ: ILMN) today announced a multi-year partnership with Agendia N.V., a world leader in precision oncology for breast cancer, to co-develop in vitro diagnostic (IVD) tests for oncology testing. The partnership is intended to advance the use of next-generation sequencing (NGS) for decentralized oncology testing and aligns with Illumina's approach to IVD partnerships in oncology. Agendia joins Illumina's growing portfolio of more than 30 IVD partners developing over 40 sequencing-based solutions for cancer prognosis, therapy selection and other applications.
Illumina, Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced a multi-year agreement to accelerate medicines development through large-scale genomics and the establishment of a preeminent clinico-genomic resource. Using Illumina's next-generation sequencing (NGS) platforms, scientists and researchers will be able to better identify disease associations and targets for intervention by analyzing data derived from VUMC's extensive, high-quality biobank of approximately 250,000 de-identified human DNA samples and associated longitudinal, structured medical data.
Illumina, Inc. (NASDAQ:ILMN) Chief Executive Officer, Francis deSouza, discussed the company's strong growth trajectory, including 2021 results and 2022 guidance. deSouza also announced new partnerships and technologies that will advance the company's mission of improving human health by unlocking the power of the genome.
In celebration of National Blood Donor Month AEG’s LA Kings and the Kings Care Foundation recently kicked off its blood drive series in conjunction with Children’s Hospital Los Angeles (CHLA) at Crypto.com Arena (formerly STAPLES Center).
Through the partnership, the restaurant giant is hoping to attract customers who are eating less meat but may not want to follow strict vegetarian or vegan diets.
In a recent TEDxOshkosh talk, Kimberly-Clark’s chief scientist Pete Dulcamara discussed how a new focus on humanity-centric innovation can help solve the most significant problems facing society and the environment.
Cascale organizes and participates in a series of events, leveraging its position as a global convener of close to half the sector to bring together...
The communities where Chemours operates are also where we live, work, and play, and our mutual success is one and the same. We have a vested interest...
Trane Technologies is a global climate innovator with a clear purpose to boldly challenge what’s possible for a sustainable world. See how embedding...
Talented employees are the heart and soul of our company. We believe development inspires individuals to engage, empower, and embrace a growth mindset...
Everyone’s financial journey is different. We make intentional efforts to meet the individual needs of clients and communities through a diverse range...
Cascale shares updates from its Board of Directors who serve as the principal governing body and are responsible for setting the strategic direction...
